Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy

International Journal of Urology

Volumn 10, Issue 6, 2003, Pages 302-306

  Önder, Ali Ulvi ^a   Yaycioglu, Ozgur ^a,b   Ataus, Suleyman ^a   Gul, Umit ^a   Demirkesen, Oktay ^a   Yalcin, Veli ^a   Solok, Vural ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Biopsy; Neoplasm staging; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER INVASION; CANCER STAGING; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SURGICAL TECHNIQUE; TRANSITION ZONE BIOPSY;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0037783799     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00622.x     Document Type: Article

References (27)

1. Lui PD, Terris MK, McNeal JE et al. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J. Urol. 1995; 153: 1000-3.
2. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate antigen values. J. Urol. 1995; 154: 1795-7.
3. Fowler JE, Condon MA, Terrel FL. Cancer diagnosis with prostate specific antigen greater then 10 ng/mL and negative peripheral zone prostate biopsy. J. Urol. 1996; 156: 1370-4.
4. Fleshner NE, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J. Urol. 1997; 157: 556-8.
5. Onder AU, Yacin V, Arar O et al. Impact of transition zone biopsies in detection and evaluation of prostate cancer. Eur. Urol. 1998; 33: 542-8.
6. Morote J, Lopez M, Encabo G. Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time. Eur. Urol. 1999; 35: 294-7.
7. Chang JJ, Shinohara K, Hovey RM, Montgomery C, Presti JC Jr. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. Urology 1994; 52: 89-93.
8. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J. Urol. 1993; 152: 1826-30.
9. Adolfsson J, Steineck G, Whitmore WF. Recent results of management of palpable localized prostate cancer. Cancer 1991; 72: 310-2.
10. Tempany CMC, Rahmouni AD, Epstein JI, Walsh PC, Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer: Evaluation with MR imaging. Radiology 1972; 181: 107-12.
11. Byar DP, Mostofi FK. Carcinoma of the prostate: Prognostic evaluation of certain pathological features in 208 radical prostatectomies examined by step-section technique. Cancer 1990; 30: 5-13.
12. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer: Significance of natural history and treatment. Am. J Surg. Pathol. 1993; 14: 240-7.
13. Partin AW, Pound CR, Clemens CQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. North Am. 1996; 20: 713-25.
14. Smith RC, Partin AW, Epstein JI, Brendler CB. Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular perforation. J Urol. 1997; 156: 454-8.
15. Smith JA, Scardino PT, Resnick MI, Hernandez AD, Rose SC, Egger MJ. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: Results of a prospective, multi-institutional trial. J. Urol. 1996; 157: 902-6.
16. Perrotti M, Kaufman RP, Jennings TA et al. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: Is it accurate? J. Urol. 1995; 156: 106-9.
17. Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA. Sextant prostate biopsies: a histopathological correlation with radical prostatectomy specimens. Cancer 1998; 75: 530-8.
18. Wills ML, Sauvageot J, Partin AW, Gurganus R, Epstein JI. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1997; 151: 759-64.
19. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC Jr. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology 1999; 50: 373-8.
20. Tigrani VS, Bhargava V, Shinohara K, Presti JC Jr. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 1999; 54: 689-93.
21. Öbek C, Louis P, Civantos F, Soloway MS. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J. Urol. 1999; 161: 494-9.
22. Epstein IJ, Lecksell K, Carter B. Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate. Urology 1998; 54: 291-4.
23. Vollmer RT, Keetch DW, Humphery PA. Predicting the pathology results of radical prostatectomy from preoperative information a validation study. Cancer 1997; 83: 1567-80.
24. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1995; 277: 1445-51.
25. Terris MK, Haney DJ, Johnstone IM, McNeal JE, Stamey TA. Prediction of prostate cancer Volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 1998; 45: 75-80.
26. Egevad L, Norberg M, Mattson S, Norlen BJ, Busch C. Estimation of prostate cancer Volume by multiple core biopsies before radical prostatectomy. Urology 2001; 52: 653-8.
27. Liu IJ, Macy M, Lai YH, Terris MK. Critical evaluation of the current indications for transition zone biopsies. Urology 2001; 57: 1117-20.